Tag: Biotech
Correction mainly hits values from the second row
Dusseldorf Nasdaq minus nine percent, Dow Jones minus three and a half and Dax plus/minus zero. That’s the tally since Dec. 27, when global weakness in tech stocks began. “Investors…
Financing boom in the pharmaceutical industry: German biotechs lure
Frankfurt German biotech companies were able to raise around 2.3 billion euros in capital last year. This was the second-highest amount of financing for the industry in its 30-year history.…
Curevac share: head of technology leaves biotech company
Mariola Fotin-Mleczek Curevac’s Chief Technology Officer will leave the company at the end of January. (Photo: CureVac) Frankfurt At the Tübingen Curevac, the upheaval continues with another prominent departure from…
Germany could shape future megatrends
Dusseldorf For many years, technology experts feared that Germany could fall behind when it came to biotech innovations. That has changed radically with the success of the Mainz-based biotechnology company…
Munich-based biotech company plans to go public on the Nasdaq
Radionuclide Cancer Therapy ITM has been producing radioisotopes for pharmaceutical companies from all over the world since the company was founded. (Photo: ITM) Frankfurt According to financial circles, the Munich-based…
Bayer and Pfizer secure alliances worth billions
Frankfurt, Düsseldorf In the search for new opportunities in the fight against diseases, this technology is considered to be one of the greatest hopes: By editing genes, certain sections of…
Bayer enters into partnership with Mammoth Biosciences
Jennifer Doudna The winner of the Nobel Prize in Chemistry is one of the founders of Mammoth Biosciences. (Photo: Getty Images) Frankfurt Bayer is stepping up its involvement in the…
The deputy editor-in-chief’s weekly review
Good morning dear readers,the world is facing a tech revolution. We will see more technological advances in the next few years than in the past hundred. This already rapid development…
The deputy editor-in-chief’s weekly review
Good morning dear readers,the world is facing a tech revolution. We will see more technological advances in the next few years than in the past hundred. This already rapid development…
Biontech and Pfizer expand vaccine alliance
Vaccine from Biontech and Pfizer The first clinical studies for the new vaccine are scheduled to start in the second half of the year. (Photo: Reuters) Frankfurt After the huge…
Using killer cells to fight cancer: researchers are promoting CAR therapy
Biontech boss Ugur Sahin, Medigene boss Dolores Schendel, patient Emily Whitehead From the point of view of many experts, the novel immunotherapies mark a new era in cancer treatment, Frankfurt…
Using killer cells to fight cancer: researchers are promoting CAR therapy
Biontech boss Ugur Sahin, Medigene boss Dolores Schendel, patient Emily Whitehead From the point of view of many experts, the novel immunotherapies mark a new era in cancer treatment, Frankfurt…
$ 900 million deal with pharmaceutical company BMS
Immatics laboratory in Tübingen The biotech company, founded in 2000, develops novel therapies against cancer. (Photo: Immatics Biotechnologies GmbH) Frankfurt The Tübingen-based biotech company Immatics signs a development and marketing…
Record funding for German cancer specialist Emergence Therapeutics
Tumor cells Illustration of breast cancer treatment with an antibody drug. (Photo: picture-alliance / medicalpictur) Frankfurt The Duisburg-based biotech company Emergence Therapeutics has raised a total of 87 million euros…
Omikron variant is fueling the need for genetic diagnostics
Genome Sequencing in India Sequencing is still indispensable for the detection of new virus variants. (Photo: Bloomberg) Frankfurt New waves of corona infection in numerous countries and the spread of…
“Traffic light” brings General against Corona – Handelsblatt Morning Briefing
The interested contemporary who wants to have a say in the virological daily discussions has just got used to the combination “B.1.1.529” and has to rethink it again. Now the…
How the Merck Group wants to revamp its pharmaceutical research
Frankfurt With several new developments and a new, more focused research strategy, the Darmstadt-based Merck Group wants to keep its pharmaceuticals division on a long-term growth path. “We want to…
Biotech and semiconductor boom boosts group
Frankfurt The business with semiconductor materials and precursors for the biotech and pharmaceutical industries as well as some new developments in the pharmaceuticals division continue to prove to be very…
Biotech and semiconductor boom boosts group
Merck Merck raised its forecast for the year a week ago. (Photo: dpa) Frankfurt The business with semiconductor materials, precursors for the biotech and pharmaceutical industries as well as some…
How Mainz benefits from the vaccine boom
Mainz The Rhineland-Palatinate state capital wants to distinguish itself as a biotech location. (Photo: picture alliance / Zoonar) Mainz The rapid rise of the biotech company Biontech will bring the…